Analysis of genetic polymorphisms in both co-receptor and cofactor
p75 and TROY genes, did not display any significant differencewithin the
tested SNPs of their respective genes in the schizophrenia sufferers compared
to their controls (p N 0.05). To our knowledge, no previous reports
have investigated the role of genetic polymorphisms in the p75 and
TROY genes in the susceptibility for schizophrenia however, our tested
SNP in the TROY gene has been previously implicated in the genetic vulnerability
of another neurological disorder (vascular dementia [29]).